Edition:
India

Aurora Cannabis Inc (ACB.TO)

ACB.TO on Toronto Stock Exchange

10.57CAD
23 Feb 2018
Change (% chg)

$-0.20 (-1.86%)
Prev Close
$10.77
Open
$10.79
Day's High
$10.83
Day's Low
$10.57
Volume
4,045,601
Avg. Vol
19,410,199
52-wk High
$15.20
52-wk Low
$1.90

Select another date:

Wed, Feb 14 2018

BRIEF-Aurora Cannabis Signed LoI With Société Des Alcools Du Québec

* AURORA CANNABIS - SIGNED LOI WITH SOCIÉTÉ DES ALCOOLS DU QUÉBEC TO SUPPLY A MINIMUM OF 5,000 KG OF CANNABIS/ANNUM FOR QUEBEC ADULT CONSUMER MARKET Source text for Eikon: Further company coverage:

BRIEF-Aurora Posts Q2 Revenues Of C$11.7 Million Vs C$3.9 Million

* AURORA CANNABIS INC QTRLY ‍REVENUES OF C$11.7 MILLION VERSUS C$3.9 MILLION

BRIEF-Aurora Cannabis And Cannimed Therapeutics File Offer Documents For Previously Announced Friendly Acquisition

* AURORA CANNABIS AND CANNIMED THERAPEUTICS FILE OFFER DOCUMENTS FOR PREVIOUSLY ANNOUNCED FRIENDLY ACQUISITION Source text for Eikon: Further company coverage:

BRIEF-Aurora Cannabis And Liquor Stores N.A. Announce Investment To Develop Western Canadian Retail Cannabis Business

* AURORA CANNABIS AND LIQUOR STORES N.A. ANNOUNCE INVESTMENT TO DEVELOP WESTERN CANADIAN RETAIL CANNABIS BUSINESS

BRIEF-Aurora Cannabis Receives Cultivation License From Health Canada For Hybrid Greenhouse Facility

* AURORA CANNABIS SAYS HAS RECEIVED A CULTIVATION LICENSE FROM HEALTH CANADA FOR AURORA SKY, CO'S MORE THAN 800,000 SQ. FT HYBRID GREENHOUSE FACILITY Source text for Eikon: Further company coverage:

Canada's Aurora Cannabis to buy rival to create world's most valuable weed firm

Canada's No. 2 marijuana producer Aurora Cannabis Inc has agreed to buy smaller rival CanniMed Therapeutics Inc for C$1.1 billion ($852 million) as companies jostle to benefit from the country's legalization of recreational marijuana use later this year. | Video

Canada's Aurora Cannabis to buy rival to create world's most valuable weed firm

Canada's No. 2 marijuana producer Aurora Cannabis Inc has agreed to buy smaller rival CanniMed Therapeutics Inc for C$1.1 billion ($852 million) as companies jostle to benefit from the country's legalization of recreational marijuana use later this year. | Video

UPDATE 4-Canada's Aurora Cannabis to buy rival to create world's most valuable weed firm

Jan 24 Canada's No. 2 marijuana producer Aurora Cannabis Inc has agreed to buy smaller rival CanniMed Therapeutics Inc for C$1.1 billion ($852 million) as companies jostle to benefit from the country's legalization of recreational marijuana use later this year.

BRIEF-Aurora Cannabis, Cannimed Therapeutics Agree To Terms On Friendly Transaction

* AURORA CANNABIS AND CANNIMED THERAPEUTICS AGREE TO TERMS ON FRIENDLY TRANSACTION

BRIEF-CanniMed Therapeutics Announces Continuation Of Discussions With Aurora

* CANNIMED THERAPEUTICS INC - ‍ IS CONTINUING TO DISCUSS TERMS OF A POSSIBLE TRANSACTION WITH AURORA CANNABIS INC​

Select another date: